Evaluation
*
Please use the scale: 1=Very poor, 2=Poor, 3=Neutral, 4=Good, 5=Excellent
12345
Overall evaluation
Content
Usefulness
Quality
*
Please use the scale: 1=Strongly disagree, 2=Disagree, 3=Neutral, 4=Agree, 5=Strongly agree
12345
Review the recently released data for PD-1 therapies in the treatment of melanoma
Analyze the strategies to apply novel PD-1 specific treatments to the care of patients with melanoma
*
*
Please use the scale: 1=NOT at all confident, 2=Not very confident, 3=Somewhat confident, 4=Confident, 5=Very confident
12345
Develop personalized treatment plans for patients with metastatic melanoma?
Apply novel PD-1 specific therapeutics when treating your patients with metastatic melanoma?
*
*
*
Please use the scale: 1=Never, 2=Not often, 3=Sometimes, 4=Often, 5=Always, N/A=Not applicable for me
12345N/A
Address patient-specific disease progression and develop individualized treatment plans for your metastatic melanoma patients based on newly introduced immunotherapies.
Utilize current science and clinical trial data to develop a strategy for applying novel PD-1 specific treatment options to a heterogenic patient population to improve long term survival rates.